Cargando…
NK Cell Plasticity in Cancer
Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest tha...
Autores principales: | Liu, Sizhe, Dhar, Payal, Wu, Jennifer D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780970/ https://www.ncbi.nlm.nih.gov/pubmed/31546818 http://dx.doi.org/10.3390/jcm8091492 |
Ejemplares similares
-
NK cell-based cancer immunotherapy: from basic biology to clinical development
por: Liu, Sizhe, et al.
Publicado: (2021) -
Plasticity of NK cells in Cancer
por: Corvino, Dillon, et al.
Publicado: (2022) -
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
por: Basher, Fahmin, et al.
Publicado: (2020) -
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
por: Dhar, Payal, et al.
Publicado: (2021) -
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)